Improving Patient Adherence and Quality
of Life in Insomnia: Strategies for Managing Treatment Related
Adverse Events Associated with Newer Therapies
A continuing medical education
activity provided by NAMCP and AAMCN
Novel Treatment Advances and Approaches in the Management of
Insomnia: Managed Care Considerations in an Evolving Management
Paradigm is a three-part webinar series
This is Part 2 of the series focusing on improving patient
adherence and quality of life in insomnia
This activity is an archive from the webinar held October 29, 2020
This activity is valid from December 1, 2020 to December 1, 2022
Instructions for CME/NCPD: Complete the pre-test, listen to the
audio and view the slides, complete the post test, complete the
evaluation form and hit submit. You will be asked to enter your name
and email address on the pre-test, evaluation and post-test. If you
close your internet browser without completing the post test, you
will have ONE more opportunity to complete. A score of 70% must be
achieved on the post test to receive continuing education credits.
If you do not pass the post test after two attempts, you will not be
eligible to try again. Once you complete the evaluation form and
score 70% or higher on your post test, you will automatically be
given your certificate.
To print or save your certificate, you will need to click on the
“download” button and either print or save.
This activity is intended for healthcare professionals practicing in
managed care environments.
This activity is supported by
an educational grant from Eisai
Insomnia is a sleep disorder which makes it difficult to fall asleep
or stay asleep, even when a person has the chance to do so. This can
affect a person’s sleep so much that they still feel tired after
they wake up. The dangers of insomnia can affect more than just a
person’s mood as people and if not treated properly can lead to
other effects such as anxiety, depression, irritability,
concentration problems, memory problems, poor immune system
function, and reduced reaction time. There are 60 million Americans
affected by the disease. About 25% of Americans experience acute
insomnia each year with around 10% experiencing chronic insomnia.
Upon completion of this
activity, participants will be able to:
Describe the clinical and economic
impact of insomnia on quality of life and risk of psychiatric
and physical illnesses
Examine treatment guidelines and
differentiate current and newer treatments, including efficacy
and safety considerations
Apply the latest clinical data on
novel and emerging therapies, including dual orexin receptor
antagonists, to the treatment of patients with insomnia
Examine the clinical data for the
safety and efficacy profiles for pharmacologic therapies for the
treatment of insomnia and untreated insomnia
||David N. Neubauer, MD
Department of Psychiatry and Behavioral Sciences
Johns Hopkins University School of Medicine
Neubauer serves as a consultant for Abbott Laboratories
and Eisai. His presentation has been peer reviewed for
MD has no real or perceived financial relationships to
Jeremy Williams has no real or perceived financial
relationships to disclose.
Jacqueline Cole, RN, MS, CMCN has no real or perceived
financial relationships to disclose.
NAMCP and/or the presenter
has copyright or has received permissions for use of
materials provided in this activity.
Accreditation & Designation
This activity has been planned and implemented in accordance with
the accreditation requirements and policies of the Accreditation
Council for Continuing Medical Education (ACCME) through the joint
providership of the National Association of Managed Care Physicians
(NAMCP) and American Association of Managed Care Nurses (AAMCN). The
National Association of Managed Care Physicians is accredited by the
ACCME to provide continuing medical education for physicians.
NAMCP designates this enduring material for a maximum of 1 AMA
PRA Category 1 credit(s)TM. Each
physician should claim credit commensurate with the extent of their
participation in the activity.
The American Association of Managed Care Nurses is accredited as a
provider of nursing continuing professional development by the
American Nurses Credentialing Center's Commission on Accreditation.
Nurses who complete this activity and achieve a passing score will
receive 1 hour in nursing continuing professional development.
This activity has been approved by the American Board of Managed
Care Nursing for 1.0 contact hours toward CMCN recertification
This activity is supported by an educational grant from
NAMCP and/or this website does not
provide medical advice, diagnosis or treatment. NAMCP does not
endorse or imply endorsement of the content on any linked website.
This website is to be used as an informational resource. With any
health related concern, consult with your physician or healthcare
Click Here To Continue